Some in vitro and in vivo studies in the literature support the role of LCN2 as a tumor promoter (35), but the difference is that in most of the current studies, LCN2 is generally considered to be a protective factor in CRC (36–38). This evidence concerns the gene LCN2 and neoplasm.